In a step toward treating mitochondrial diseases, researchers in the Netherlands have successfully edited harmful mutations ...

CRSP edges ahead of NTLA with the only approved CRISPR therapy, stronger pipeline breadth and recent stock gains.

The duration of expression of the gene Cdx2 is tightly regulated by a newly identified DNA sequence element called an ...

Scientific organizations recently called for a 10-year ban on human germline editing. But will we ever be ready? And how ...

CRISPR Therapeutics (NASDAQ:CRSP) operates within the biotechnology segment, which remains active across key indices like the ...

Scientists at Bose Institute have developed a CRISPR-based smart gene switch that helps plants fight heat and infections only ...

Repositioning genes awakens fetal hemoglobin to treat disease. CRISPR editing may change future gene therapy. Researchers ...

We came across a bullish thesis on CRISPR Therapeutics AG (CRSP) on Two Natural Cap’s Substack. In this article, we will ...

Using gene editing in a preclinical model, researchers at UT Southwestern Medical Center blocked the symptoms of a rare smooth muscle disease before they developed. Their findings, published in ...

The promising field of genomics has undergone rapid evolution over the past decade. Genomics includes the study of a complete set of genes, their work process and way of interacting with each other ...

Centre has assured multiple times that all IPR concerns linked to gene-edited rice will be addressed and farmers will not ...

Moving toward clinical development, the researchers demonstrated efficient delivery of mRNA mitochondrial base editors using ...